Most Popular

    Phase 3 Trial Currently Enrolling MacTel Patients

    Phase 3 Trial Currently Enrolling MacTel Patients

    In a collaboration with Neurotech Pharmaceuticals, the Lowy Medical Research Institute is currently enrolling a Phase 3 clinical trial testing ciliary neurotrophic factor (CNTF) in patients with macular telangiectasia type 2.  This is a multi-center...

    CNTF Clinical Trials: COVID-19 Update

    CNTF Clinical Trials: COVID-19 Update

    March 24, 2020 The rapid spread of COVID-19 has disrupted many standard clinical operations, including the LMRI/Neurotech Phase 1, 2, and 3 clinical trials testing CNTF in MacTel. If you have questions regarding upcoming appointments or other study-...

    Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia

    Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia

    Neurotech Pharmaceuticals, Inc., in collaboration with the Lowy Medical Research Institute (LMRI), today announced 24-month results demonstrating that NT-501 delivering Ciliary Neurotrophic Factor (CNTF) has a beneficial effect in patients with Macul...

    CNTF Phase 3 Trial Enrollment Complete

    CNTF Phase 3 Trial Enrollment Complete

    September 21, 2020 In a collaboration with Neurotech Pharmaceuticals, the Lowy Medical Research Institute is conducting a Phase 3 clinical trial testing ciliary neurotrophic factor (CNTF) in patients with macular telangiectasia type 2.  This is a...

    Results of NT-501 Phase 2 Study Published

    Results of NT-501 Phase 2 Study Published

    January 16, 2019, Cumberland, RI and La Jolla, CA. The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration with the Lowy Medical Research Institute (LMRI), have been published in the journal o...

    Lowy Medical Research Institute scientists find cause of debilitating eye disease

    Lowy Medical Research Institute scientists find cause of debilitating eye disease

    15-year effort points to treatments to help MacTel patients and offers potential new insights into other eye diseases LA JOLLA, CA–September 11, 2019– Scientists at the Lowy Medical Research Institute (LMRI) have discovered one cause of a progre...